Abiopharma

News list

(85% Positive) Cassava Sciences, Inc. (SAVA) Provides Update on time for Cassava

Full text

News bot Oct. 22, 2025, 12:14 p.m.
📋 Cassava Sciences, Inc. (SAVA) - Clinical Trial Update

Filing Date: 2025-10-22

Accepted: 2025-10-22 08:12:12

Event Type: Clinical Trial Update
Event Details:
Cassava Sciences Inc. (SAVA) Announces Clinical Trial Update Cassava Sciences Inc. (SAVA) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: time, simufilam
Diseases/Conditions: Cassava
Clinical Stage: clinical study
Collaboration: the Board of Cassava
Updated Timeline: October 22, 2025
💼 Business Developments:
- Partnership
- Acquisition
- Licensing
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Cassava Sciences Inc.
- CIK: 0001069530
- Ticker Symbol: SAVA
- Period End Date: 2025-10-21
- Document Type: 8-K